1. Home
  2. STKH vs CNSP Comparison

STKH vs CNSP Comparison

Compare STKH & CNSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Steakholder Foods Ltd.

STKH

Steakholder Foods Ltd.

HOLD

Current Price

$2.62

Market Cap

3.6M

ML Signal

HOLD

Logo CNS Pharmaceuticals Inc.

CNSP

CNS Pharmaceuticals Inc.

HOLD

Current Price

$6.07

Market Cap

4.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
STKH
CNSP
Founded
2018
2017
Country
Israel
United States
Employees
N/A
N/A
Industry
Packaged Foods
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.6M
4.0M
IPO Year
2021
2019

Fundamental Metrics

Financial Performance
Metric
STKH
CNSP
Price
$2.62
$6.07
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$20.00
AVG Volume (30 Days)
122.4K
17.7K
Earning Date
04-02-2026
11-17-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$10,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.13
$4.93
52 Week High
$72.80
$114.00

Technical Indicators

Market Signals
Indicator
STKH
CNSP
Relative Strength Index (RSI) 40.78 38.99
Support Level $2.44 $6.00
Resistance Level $2.70 $7.78
Average True Range (ATR) 0.32 0.60
MACD -0.03 -0.08
Stochastic Oscillator 4.24 9.52

Price Performance

Historical Comparison
STKH
CNSP

About STKH Steakholder Foods Ltd.

Steakholder Foods Ltd is engaged in transforming the alternative protein industries through its technology. The group specializes in developing and selling 3D-printing production machines, supported by proprietary premix blends, formulated from the highest-quality raw ingredients. These tools help manufacturers of all sizes efficiently produce foods that meet consumer expectations for taste, texture, and appearance and offer a safe and sustainable alternative to industrialized meat and seafood production. The company's expertise in creating alternative protein products replicating traditional meats' complex textures such as beef steaks, white fish, shrimp, and eel. It also explores the integration of cultivated cells, preparing for future advancements in food technology.

About CNSP CNS Pharmaceuticals Inc.

CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.

Share on Social Networks: